Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Cummings JL, Cohen S, van Dyck CH, Brody M, et al. ABBY: A phase 2 randomized trial of crenezumab in mild to moderate Alzheimer disease. Neurology 2018 Apr 25. pii: WNL.0000000000005550.
PMID: 29695589


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016